"Combining a novel molecule in discovery and development to work synergistically with a molecule in late-stage development or a marketed product offers benefits in the development stage, commercially and to the patient. This strategy can be used to maximize efficacy, minimize individual toxicity and simultaneously target multiple pathologic processes in many disease areas. This session will offer perspectives on the value of combination therapies in these disease areas, the discovery and development challenges, and case studies of projects that are required to bring unique value to the clinic and market."

Objective 1:Insight on the discovery process of combination therapies in disease areas, including cancer, autoimmune/inflammatory diseases.

Objective 2: Review challenges and benefits of combination therapies throughout the development process.

Objective 3:Provide overview of commercial value of combination therapies.